Show simple item record

dc.contributor.advisorRobert A. Greenes,. John B. Wong and Stephen G. Pauker.en_US
dc.contributor.authorSondhi, Manuen_US
dc.contributor.otherHarvard University--MIT Division of Health Sciences and Technology.en_US
dc.date.accessioned2006-08-25T18:50:34Z
dc.date.available2006-08-25T18:50:34Z
dc.date.copyright2005en_US
dc.date.issued2005en_US
dc.identifier.urihttp://hdl.handle.net/1721.1/33846
dc.descriptionThesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology, 2005.en_US
dc.descriptionIncludes bibliographical references (leaves 74-76).en_US
dc.description.abstractBackground: Estimation of cost-effectiveness of a therapy as compared with another, in healthcare, is often based on a single perspective and a single time horizon. In this thesis, I explored methods of extrapolating the survival effect of different interventions and the effect of time horizon on incremental cost-effectiveness ratios when comparing two strategies. Methods: Two strategies for a patient are compared: new or usual treatment. A hypothetical model based on US life tables (for a 64-year old) assumed that the new and usual treatment strategies resulted in patient survivals identical to a person who is 5 and 10 years older, respectively, than the patient's chronologic age. The hazard rates over time were calculated and transformed to linear equations for least-squares linear regression to fit exponential, linear exponential, Weibull and Gompertz distributions. The survival model yielding the maximal likelihood estimate was extrapolated over different time horizons: 5, 10 and 15-year in addition to lifetime. In addition, I extracted survival data from a published trial evaluating thrombolysis in patients with myocardial infarction and applied this methodology over different time horizons.en_US
dc.description.abstract(cont.) Finally, I developed a matrix of incremental cost-effectiveness ratios over different time horizons, based on an overview model, examining alternative assumptions when the cumulative difference in cost and effectiveness of the two strategies: 1) decrease 2) remain constant or 3) increase. I used a statistical programming language "R" for evaluation and analysis. Results: When considering a US life-table based hypothetical model, Gompertz curve was the best-fitting model. A linear-exponential model had the best fit when considering a survival model of thrombolysis patients. A matrix of incremental cost-effectiveness ratios with decreasing, constant and increasing cumulative difference in cost and effectiveness showed considerable change in incremental cost-effectiveness ratios over different time horizons. The magnitude of effect of time horizon was flattened with increasing discount rate for future cumulative differences in cost and effectiveness. With the exception of similarly behaving and proportionate cumulative difference in cost and effectiveness leading to unchanged incremental cost-effectiveness ratios, incremental cost-effectiveness ratios decreased when cumulative difference in effectiveness increased and increased when cumulative difference in effectiveness decreased, irrespective of behavior of cumulative difference in costs.en_US
dc.description.abstract(cont.) Conclusions: When conducting cost-effectiveness analysis of two competing strategies, choice of time horizon has a substantial effect. Incremental cost-effectiveness ratio changes considerably with changes in duration of time horizon. Discounting flattens the effect of time horizon in cost-effectiveness analysis. Care must be taken in choosing the time horizon in a cost-effectiveness analysis and alternative time horizons must be evaluated in all cost-effectiveness analyses.en_US
dc.description.statementofresponsibilityby Manu Sondhi.en_US
dc.format.extent76 leavesen_US
dc.format.extent3854827 bytes
dc.format.extent3857937 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypeapplication/pdf
dc.language.isoengen_US
dc.publisherMassachusetts Institute of Technologyen_US
dc.rightsM.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.en_US
dc.rights.urihttp://dspace.mit.edu/handle/1721.1/7582
dc.subjectHarvard University--MIT Division of Health Sciences and Technology.en_US
dc.titleEffect of time horizon on incremental cost-effectiveness ratiosen_US
dc.typeThesisen_US
dc.description.degreeS.M.en_US
dc.contributor.departmentHarvard University--MIT Division of Health Sciences and Technology
dc.identifier.oclc65466453en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record